Search

everythinglearnresearchcommunity

for

Search:↓

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Triamcinolone regrows hair better but relapses more than anthralin.

Alopecia areata affects women and young adults most, with low SDI regions seeing the highest increase, and new treatments like JAK inhibitors are being explored.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Targeting CXCL10 may help treat alopecia areata.

Baricitinib works better than methotrexate for severe alopecia areata.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

A woman's hair loss condition got worse after her varicose vein treatment with a specific foam.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Dupilumab can both trigger and treat alopecia areata, often leading to hair regrowth.

Autologous follicular stem cells improved hair loss in 57% of patients.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Mometasone furoate cream was more effective than bimatoprost solution for treating hair loss from Alopecia Areata.